SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

O'Keefe Kevin Richard

(Last)

(First)

(Middle)

EMERALD EXPOSITIONS EVENTS, INC.

31910 DEL OBISPO STREET, SUITE 200

(Street)

SAN JUAN CAPISTRANO

92675

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/22/2018

3. Issuer Name and Ticker or Trading Symbol
Emerald Expositions Events, Inc. [ EEX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	17,414⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	04/22/2015⁽²⁾	04/22/2024	Common Stock	19,500	$8	D
Stock Option (Right to Buy)	04/22/2015⁽³⁾	04/22/2024	Common Stock	25,000	$12	D
Stock Option (Right to Buy)	04/22/2015⁽³⁾	04/22/2024	Common Stock	25,000	$16	D
Stock Option (Right to Buy)	06/18/2015⁽⁴⁾	06/18/2024	Common Stock	6,250	$8	D
Stock Option (Right to Buy)	06/18/2015⁽⁵⁾	06/18/2024	Common Stock	3,125	$12	D
Stock Option (Right to Buy)	06/18/2015⁽⁵⁾	06/18/2024	Common Stock	3,125	$16	D
Stock Option (Right to Buy)	08/26/2016⁽⁶⁾	08/26/2025	Common Stock	9,375	$12	D
Stock Option (Right to Buy)	08/26/2016⁽⁷⁾	08/26/2025	Common Stock	3,125	$16	D
Stock Option (Right to Buy)	01/22/2019⁽⁸⁾	01/22/2028	Common Stock	34,903	$22.08	D
Stock Option (Right to Buy)	09/18/2019⁽⁹⁾	09/18/2028	Common Stock	47,415	$16.5	D

Explanation of Responses:

1. Includes 17,414 unvested restricted stock units.

2. This option is vested with respect to 9,500 underlying shares and will vest with respect to the remaining 10,000 underlying shares on April 22, 2019.

3. This option is vested with respect to 20,000 underlying shares and will vest with respect to the remaining 5,000 underlying shares on April 22, 2019.

4. This option is vested with respect to 5,000 underlying shares and will vest with respect to the remaining 1,250 underlying shares on June 18, 2019.

5. This option is vested with respect to 2,500 underlying shares and will vest with respect to the remaining 625 underlying shares on June 18, 2019.

6. This option is vested with respect to 5,625 underlying shares and will vest with respect to the remaining 3,750 underlying shares in equal installments on August 26, 2019 and August 26, 2020.

7. This option is vested with respect to 1,875 underlying shares and will vest with respect to the remaining 1,250 underlying shares in equal installments on August 26, 2019 and August 26, 2020.

8. This option is vested with respect to 0 underlying shares and will vest with respect to the remaining 34,903 underlying shares in equal installments on January 22, 2019, January 22, 2020, January 22, 2021 and January 22, 2022.

9. This option is vested with respect to 0 underlying shares and will vest with respect to the remaining 47,415 underlying shares in equal installments on September 18, 2019, September 18, 2020, September 18, 2021 and September 18, 2022.

	/s/ David Gosling, Attorney-in-Fact	10/30/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.